(Q28243274)

English

CCK and NPY as anti-anxiety treatment targets: promises, pitfalls, and strategies

scientific article (publication date: October 2006)

In more languages

edit

Statements

0 references

1 reference

Europe PubMed Central

title

CCK and NPY as anti-anxiety treatment targets: promises, pitfalls, and strategies (English)

0 references

author name string

J Harro

series ordinal

1

0 references

language of work or name

English

0 references

publication date

October 2006

0 references

published in

Amino Acids

0 references

volume

31

0 references

issue

3

0 references

page(s)

215-30

0 references

cites work

The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00726-006-0334-X

retrieved

21 January 2018

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00726-006-0334-X

retrieved

21 January 2018

Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00726-006-0334-X

retrieved

21 January 2018

Cholecystokinin and anxiety in normal volunteers: an investigation of the anxiogenic properties of pentagastrin and reversal by the cholecystokinin receptor subtype B antagonist L-365,260

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00726-006-0334-X

retrieved

21 January 2018

CSF cholecystokinin concentrations in patients with panic disorder and in normal comparison subjects.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00726-006-0334-X

retrieved

21 January 2018

Behavioral differences in an elevated plus-maze: correlation between anxiety and decreased number of GABA and benzodiazepine receptors in mouse cerebral cortex

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00726-006-0334-X

retrieved

21 January 2018

Identifiers

DOI

10.1007/S00726-006-0334-X

0 references

PubMed publication ID

16738800

0 references

(Q28243274)

CCK and NPY as anti-anxiety treatment targets: promises, pitfalls, and strategies

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)